2-[2--1H-Pyrrolo[2,3-D]Pyrimidin-4-YL)Amino] Benzamide Derivatives As IGF-1R Inhibitors For The Treatment Of Cancer
                        
                            
                                申请人:Chamberlain Stanley Dawes
                            
                            
                                公开号:US20100204196A1
                            
                            
                                公开(公告)日:2010-08-12
                            
                            Novel pyrrolopyrimidines as shown in formula (I):
and pharmaceutically acceptable derivatives thereof. The compounds are useful in the inhibition of IGF-1R.
                            式(I)所示的新型
吡咯吡咪啉及其药学上可接受的衍
生物。这些化合物在抑制IGF-1R方面是有用的。